[Federal Register Volume 89, Number 48 (Monday, March 11, 2024)]
[Notices]
[Page 17475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05081]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-D-1824]


Assessing COVID-19-Related Symptoms in Outpatient Adult and 
Adolescent Subjects in Clinical Trials of Drugs and Biological Products 
for COVID-19 Prevention or Treatment; Guidance for Industry; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register on February 22, 2024. The 
document announced the availability of a final guidance for industry 
entitled ``Assessing COVID-19-Related Symptoms in Outpatient Adult and 
Adolescent Subjects in Clinical Trials of Drugs and Biological Products 
for COVID-19 Prevention or Treatment.'' The document was published with 
an incorrect docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: David Reasner, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 22, Rm. 6373, Silver Spring, MD 20993, 301-837-
7667; or James Myers, Center for Biologics Evaluation and Research, 
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 
7301, Silver Spring, MD 20993-0002, 240-402-7911.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 22, 2024 
(89 FR 13351), in FR Doc. 2024-03622, the following correction is made:
    On page 13351, in the first column in the header of the document 
and in the third column in the second line of the first paragraph, 
``Docket No. FDA-2024-D-0584'' is corrected to read ``Docket No. FDA-
2020-D-1824.''

    Dated: March 5, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-05081 Filed 3-8-24; 8:45 am]
BILLING CODE 4164-01-P